Jay Lobell Insider Profile

11 Followers
Jay Lobell, Director at Fortress Biotech, holds 1.64M shares in Fortress Biotech (Ticker: FBIO), holds 1.36M shares in Pardes Biosciences (Ticker: PRDS), holds 0.00 shares in Keryx Biopharma (Ticker: KERX). Most recently, Jay Lobell Bought ― shares of Fortress Biotech on Feb 14, 2023 for an estimated value of 248.50K.
Jay Lobell

Jay Lobell
Fortress Biotech (FBIO)
Director

Ranked #86,511 out of 102,730 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-29.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
73.65%
26.35%
A breakdown of Jay Lobell's holdings

Insider Roles

Pardes Biosciences
(PRDS)
Director
Fortress Biotech
(FBIO)
Director
Roles that Jay Lobell holds in companies

Most Profitable Insider Trade

Stock:
Fortress Biotech
(FBIO)
Rating:Informative Buy
Date:Jun 26, 2012 - Jun 26, 2013
Return:+55.40%
The most profitable trade made by Jay Lobell

Jay Lobell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Fortress Biotech
Feb 14, 2023
Director
Informative Buy
$248.50K
$907.65K
Pardes Biosciences
Jul 21, 2022
Director
Uninformative Buy
$2.54M
KERX
Keryx Biopharma
$0.00
TLON
Talon Therapeutics Inc
List of latest transactions for each holding click on a transaction to see Jay Lobell's performance on stock

Jay Lobell insider profile FAQ

What is the percentage of profitable transactions made by Jay Lobell?
The percentage of profitable transactions made by Jay Lobell is 25%.
    What is the average return per transaction made by Jay Lobell?
    The average return per transaction made by Jay Lobell is -29.80%.
      What stocks does Jay Lobell hold?
      Jay Lobell holds: FBIO, PRDS, KERX, TLON stocks.
        What was Jay Lobell’s latest transaction?
        Jay Lobell latest transaction was an Informative Buy of $248.50K.
          What was Jay Lobell's most profitable transaction?
          Jay Lobell’s most profitable transaction was an Informative Buy of FBIO stock on June 26, 2012. The return on the trade was 55.40%.
            What is Jay Lobell's role in Fortress Biotech?
            Jay Lobell's role in Fortress Biotech is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.